SNMX $1.51 MUST WATCH >> SNMX with 2 very big News 2 Werks ago. 1. The continue Firmenich coloboration + 2. the (LPC) terminate Purchase agreement. First Milestone Siratose Deal next deal ahead? why else does SNMX stop the toxic financing that they would need for the next 2 years without a big deal? I think the next few days we must see a milestone deal that trigger the begining of Multi $100 millions deal in the future. $6 my target price before 2018 imo.
Siratose the next Stevia and SNMX then a Major Company for Hufe Pepsi Coca Cola deal imo. with positiv Siratose News this week SNMX will pop 300% 400% imho. the market will then evaluate the future. SNMX would be out of nowhere as a big player. this week could bei epic imo.
Item 1.0 2 Termination of a Material Definitive Agreement
On November 14, 2017, Senomyx provided written notice to Lincoln Park Capital Fund, LLC (“LPC”) of its intent to terminate the Purchase Agreement dated December 21, 2016, between Senomyx, Inc. and LPC (the “Purchase Agreement”), such termination to be effective on November 15, 2017. Under the terms of the Purchase Agreement, Seonmyx has the right to terminate the Purchase Agreement at any time, at no cost to us. Pursuant to the Purchase Agreement, prior to termination, the Company had the right to sell to LPC from time to time in its sole discretion up to $14,000,000 in shares of the Company’s common stock over a 24 month period, subject to certain limitations and conditions set forth in the Purchase Agreement.
Senomyx Expands Cool Program Collaboration with Firmenich
SAN DIEGO, Nov. 14, 2017 /PRNewswire/ -- Senomyx, Inc. (SNMX),a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners, and Firmenich, the world's largest privately-owned company in the fragrance and flavor business, announced today the expansion of their Cool Program collaborative agreement.
With this amendment to our Cool Collaboration Agreement, Firmenich continues its long-standing tradition of investing in innovation. Under terms of the amended agreement, Firmenich will be granted an exclusive license to CoolmyxTM CL19 and related cooling ingredients in all product categories. This amendment also includes a license expansion for product categories covering applications in the flavor, oral care and consumer product markets.
"During the second quarter, Senomyx engaged an advisor to pursue strategic options related to certain flavor ingredient assets," stated John Poyhonen, President and Chief Executive Officer of Senomyx. "We have been gratified by the significant third-party interest in this family of cooling ingredients, and we believe that Firmenich's exclusive license of Coolmyx CL19 is an outstanding opportunity for both companies. Signing this amended agreement is consistent with our goal of securing non-dilutive funding to support our corporate priorities."
Under the terms of the amended agreement, Senomyx will receive an upfront payment of $10 million for the exclusive license and pre-payment of Cool Program royalty obligations covering the period from 2018 through 2020. Under the terms of the amended agreement, Firmenich's royalty payment obligations will resume in 2021 and will continue through the length of the agreement. SNMX CHART IN GOLDEN CROSS NOW >>>>>>>>>
What is a Golden Cross? Check it out » https://www.investopedia.com/terms/g/goldencross.asp https://tradingsim.com/blog/golden-cross/ http://www.otcmarkets.com/stock/SNMX/news